How Can Biotech Startups Create Value Through ESG?

Reducing environmental impact, enhancing social responsibility, and strengthening transparent governance are the three pillars of ESG (Environmental, Social, and Governance) evaluation.
With more investors and consumers favoring ESG-oriented companies, biotech startups have a unique opportunity to enhance their corporate value while achieving both business success and social impact.

By Joseph Shen, Vice President of Medical Affairs, BE Accelerator

ree

ESG in the Biotech and Healthcare Startup Context

In recent years, medical startups have increasingly prioritized ESG factors in their operations and decision-making.

  • Environmental (E):
    Reducing waste and emissions, adopting sustainable materials in manufacturing, and minimizing the environmental footprint of supply chains.

  • Social (S):
    Expanding access to healthcare, promoting workplace diversity and inclusion, and ensuring ethical practices in clinical trials and patient care.

  • Governance (G):
    Strengthening transparency, accountability, regulatory compliance, ethical leadership, and effective risk management.

As ESG adoption grows, investors are actively supporting companies committed to sustainability.
For biotech startups, this not only drives better financial performance but also fosters long-term positive social and environmental outcomes.

Five Steps to Achieve ESG Value in Biotech Startups

1. Conduct a Comprehensive ESG Assessment

Identify the environmental, social, and governance risks and opportunities related to your operations—covering supply chains, manufacturing, HR policies, and product lifecycles.

For example, a medical device startup can evaluate:

  • The environmental impact of raw materials.

  • Energy efficiency of manufacturing.

  • Product safety and clinical performance across its lifecycle.

2. Develop an ESG Strategy

Based on the assessment, formulate a clear ESG roadmap with measurable goals, KPIs, and timelines aligned with business objectives.

Examples:

  • Reduce carbon footprint.

  • Increase sustainable materials in production.

  • Promote workplace diversity and inclusion.

The ESG strategy should be reviewed and refined periodically to reflect evolving industry standards.

3. Engage Stakeholders

Active engagement with investors, employees, customers, and suppliers is critical.
Startups should communicate ESG goals and progress transparently, and seek stakeholder feedback.

Examples:

  • Host sustainability forums for investors.

  • Conduct employee surveys on inclusion initiatives.

  • Gather patient and customer feedback on product safety and efficacy.

4. Implement ESG Practices

Integrate ESG principles into daily operations—promoting sustainability, ethical behavior, and good governance.

Examples:

  • Use recycled or biodegradable packaging.

  • Implement energy-efficient manufacturing systems.

  • Ensure ethically conducted clinical trials.

  • Enhance board-level transparency and audit practices.

5. Measure and Report ESG Performance

Regularly measure progress toward ESG goals and disclose outcomes.
Establish quantitative metrics and qualitative indicators, such as:

  • Carbon footprint reduction.

  • Percentage of sustainable materials used.

  • Workforce diversity ratios.

  • Product safety and performance metrics.

Publish updates through sustainability reports, annual disclosures, or investor briefings to build trust and accountability.

Conclusion

By integrating ESG principles into their core strategy, biotech startups can foster responsible innovation, gain investor confidence, and enhance brand value—creating a future where profitability and sustainability coexist.

For more information, please contact:Joseph.Shen@be.tworg.app

Recent Posts